Cardionovum gmbh bonn
WebDec 5, 2024 · CARDIONOVUM Life deserves the best. Innovative cardiovascular therapies for a better patient care. Cardionovum feels competent for further developments in leading edge … Massimo Morero Chief Technology Officer Monika Mroczkiewicz QA & RA Director … Since the beginning in 2013, Cardionovum is represented in more than 40 countries … XLIMUS DES® Sirolimus eluting coronary stent system. XLIMUS is the ultimate … Microscopy of the ‘SAFEPAX’ balloon surface showing no visible PTX … Yanqi Yin - Yaxue Shi, et al., The American Journal of Kidney Diseases P19-27.E1, … Bonn, Germany. November 16, 2024 – Data presented at Innovation session today at … APERTO DCB® Paclitaxel releasing high pressure shunt balloon dilatation … Pre-clinical results confirm no noticeable embolization results similar to POBA. … WebVice President of Sales & Marketing at Cardionovum GmbH Bergen, Noord-Holland, Nederland. 383 volgers 378 connecties. Word lid om …
Cardionovum gmbh bonn
Did you know?
WebQM / RA Specialist bei CARDIONOVUM GmbH Bonn. Carla Kuhn MiM Finance NEOMA Business School CFA Level 1 Candidate Niza. Hay … WebCARDIONOVUM GmbH 1,760 followers on LinkedIn. CARDIONOVUM Life deserves the best. CARDIONOVUM, a medical technology company based in Bonn, Germany, …
WebBonn, North Rhine-Westphalia 97 followers Follow View all 3 employees Report this company Report Report. Back Submit. About us ... CARDIONOVUM GmbH 97 … WebJul 3, 2012 · BONN, Germany--(BUSINESS WIRE)--Cardionovum GmbH: Cardionovum GmbH announced today that it has initiated in vivo testing of its second drug-eluting balloon (DEB) RESTORE™. The Company is currently marketing a line of CE-marked paclitaxel-coated DEBs for (1) coronary (PRIMUS®) and (2) peripheral (LEGFLOW®) applications. ...
WebCardionovum GmbH. Am Bonner Bogen 2, 53227 Bonn Germany . PHONE: +49 22 89 09 72 269 FAX: +49 22 81 80 91 909 Visit Website. View US Listing. Created with Sketch. Created with Sketch. Balloons / Drug-Coated Balloons View Chart. Company Name Product Name Drug Type ... WebFind info on Manufacturing companies in Bonn, including financial statements, sales and marketing contacts, top competitors, and firmographic insights. ... Magnetfabrik Bonn GmbH. Country: Bonn, Nordrhein-westfalen ... CARDIONOVUM GmbH. Country: Bonn, Nordrhein-westfalen ...
WebAug 2, 2024 · ABOUT CARDIONOVUM® GMBH. CARDIONOVUM® GmbH is a medical technology company based in Bonn, Germany, that develops and commercializes innovative medical devices such as the new generation of drug coated balloons and drug eluting stents for the treatment of coronary and peripheral artery disease. The company’s …
WebBonn, Nordrhein-Westfalen, Deutschland. 1589 Follower:innen 500+ Kontakte. Anmelden, um das Profil zu sehen CARDIONOVUM GmbH. EAE Business School. Dieses Profil … breach of the equality act 2010WebMar 31, 2024 · ABOUT CARDIONOVUM GMBH. CARDIONOVUM GmbH is a medical technology company based in Bonn, Germany, that develops and commercializes innovative medical devices such as the new … cory caliWeb“Mehrschichtige Dekontaminationsmatte Marktforschungsbericht, 2024-2030. Globaler Mehrschichtige Dekontaminationsmatte-Markt für einen Vorhersagezeitraum von 2024 … breach of the peace actWebJun 6, 2016 · BONN – June 1, 2016 – CARDIONOVUM GmbH, a medical technology company developing and commercializing innovative medical devices such as drug-coated balloons and drug-eluting stents for the treatment of coronary and peripheral artery disease, today announced the completion of enrollment of the RAPID trial. Results will be used to … cory calkins peWebApr 12, 2014 · BONN, Germany, Dec. 4, 2014—Cardionovum GmbH announced today that it has initiated a 150-patient clinical study of its novel paclitaxel-releasing, high-pressure shunt balloon dilatation catheter, APERTO®. The study aims to sustain the highly promising and significant first clinical evidence for APERTO. cory cali attorney syracuse nyWebJun 8, 2024 · ABOUT CARDIONOVUM® GMBH. CARDIONOVUM® GmbH is a medical technology company based in Bonn, Germany, that develops and commercializes innovative medical devices such as the new generation of drug coated balloons and drug eluting stents for the treatment of coronary and peripheral artery disease. The company’s … cory camilleriWebJul 3, 2012 · BONN, Germany. Cardionovum GmbH announced today that it has initiated in vivo testing of its second drug-eluting balloon (DEB) RESTORE. The Company is currently marketing a line of CE-marked paclitaxel-coated DEBs for (1) coronary (PRIMUS®) and (2) peripheral (LEGFLOW®) applications. Cardionovum is featured in the most … breach of the month